Beahrs O H, Wilson S M
Ann Surg. 1976 Oct;184(4):422-8. doi: 10.1097/00000658-197610000-00004.
Carcinoma of the anus represents about 2% of cancers of the large bowel. From 1950 to 1970, 20 patients were treated for this condition. Included were 113 patients with squamous cell carcinoma (31 perianal), 64 with basalid squamous carcinoma, 8 with Paget's disease of the anus, 7 with melanoma, 6 with basal cell carcinoma, and 6 with adenocarcinoma. Combined abdomino-perineal resection was the treatment of choice except for perianal lesions; for these, local excision was used most frequently. Inguinal node dissection was used infrequently, and it is not possible to draw meaningful conclusions from the data. Overall survival rates for patients having anal squamous cell carcinoma are similar except when lymphatic invasion is present; then basaloid lesions have a significantly better prognosis. For rare anal carcinomas, histopathologic findings dictate the end results-- the better the findings and more satisfactory the results.
肛门癌约占大肠癌的2%。1950年至1970年期间,有20例患者接受了针对该病症的治疗。其中包括113例鳞状细胞癌患者(31例肛周癌)、64例基底鳞状癌患者、8例肛门佩吉特病患者、7例黑色素瘤患者、6例基底细胞癌患者以及6例腺癌患者。除肛周病变外,联合腹会阴切除术是首选治疗方法;对于这些病变,最常采用局部切除术。腹股沟淋巴结清扫术很少使用,且无法从这些数据中得出有意义的结论。肛门鳞状细胞癌患者的总体生存率相似,除非存在淋巴浸润;此时,基底样病变的预后明显更好。对于罕见的肛门癌,组织病理学检查结果决定最终结果——检查结果越好,结果就越令人满意。